These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 12803119

  • 1. Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
    Kinjoh K, Nakamura M, Sunagawa M, Kosugi T.
    Haematologia (Budap); 2002; 32(4):457-65. PubMed ID: 12803119
    [Abstract] [Full Text] [Related]

  • 2. Bound thrombin from crushed clots is composed of alpha-thrombin and the N-terminal regions of alpha- and gamma-chains of fibrinogen.
    Kinjoh K, Nakamura M, Gang Z, Sunagawa M, Eguchi Y, Kosugi T.
    Pathophysiol Haemost Thromb; 2002; 32(4):165-73. PubMed ID: 12759517
    [Abstract] [Full Text] [Related]

  • 3. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW, Marder VJ.
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines.
    Shainoff JR, Stearns DJ, DiBello PM, Hishikawa-Itoh Y.
    Thromb Haemost; 1990 Apr 12; 63(2):193-203. PubMed ID: 2163552
    [Abstract] [Full Text] [Related]

  • 5. Thrombin binding to the A alpha-, B beta-, and gamma-chains of fibrinogen and to their remnants contained in fragment E.
    Kaczmarek E, McDonagh J.
    J Biol Chem; 1988 Sep 25; 263(27):13896-900. PubMed ID: 3417681
    [Abstract] [Full Text] [Related]

  • 6. Binding of various thrombin fractions to fibrin and the influence of AT-III on their adsorption.
    Nilsen DW, Brosstad F, Kierulf P, Godal HC.
    Thromb Haemost; 1986 Jun 30; 55(3):352-6. PubMed ID: 3750265
    [Abstract] [Full Text] [Related]

  • 7. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA, Siebenlist KR, Bergtrom G, Mosesson MW.
    J Lab Clin Med; 1995 Mar 30; 125(3):384-91. PubMed ID: 7897305
    [Abstract] [Full Text] [Related]

  • 8. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
    Siebenlist KR, Meh DA, Wall JS, Hainfeld JF, Mosesson MW.
    Thromb Haemost; 1995 Oct 30; 74(4):1113-9. PubMed ID: 8560422
    [Abstract] [Full Text] [Related]

  • 9. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
    Krajewski T, Nowak P, Cierniewski C.
    Acta Biochim Pol; 1985 Oct 30; 32(2):144-54. PubMed ID: 4036448
    [Abstract] [Full Text] [Related]

  • 10. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
    Kumar R, Béguin S, Hemker HC.
    Thromb Haemost; 1995 Sep 30; 74(3):962-8. PubMed ID: 8571330
    [Abstract] [Full Text] [Related]

  • 11. Angiogenic activity of fibrin degradation products is located in fibrin fragment E.
    Thompson WD, Smith EB, Stirk CM, Marshall FI, Stout AJ, Kocchar A.
    J Pathol; 1992 Sep 30; 168(1):47-53. PubMed ID: 1280677
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M, Baba M, Morimoto K, Nakamikawa C.
    J Clin Invest; 1983 Sep 30; 72(3):1034-41. PubMed ID: 6886002
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
    Raut S, Gaffney PJ.
    Thromb Haemost; 1996 Jul 30; 76(1):56-64. PubMed ID: 8819252
    [Abstract] [Full Text] [Related]

  • 15. Binding of carboxypeptidase N to fibrinogen and fibrin.
    Talens S, Lebbink JH, Malfliet JJ, Demmers JA, Uitte de Willige S, Leebeek FW, Rijken DC.
    Biochem Biophys Res Commun; 2012 Oct 19; 427(2):421-5. PubMed ID: 23000409
    [Abstract] [Full Text] [Related]

  • 16. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW, Southward SM, Legault KJ, Ross BL, Clarke BJ, Bajzar L, Blajchman MA, Singh G, Richardson M.
    J Lab Clin Med; 2004 Apr 19; 143(4):241-54. PubMed ID: 15085083
    [Abstract] [Full Text] [Related]

  • 17. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
    Cierniewski CS, Kloczewiak M, Budzynski AZ.
    J Biol Chem; 1986 Jul 15; 261(20):9116-21. PubMed ID: 3722190
    [Abstract] [Full Text] [Related]

  • 18. [Isolation of the fragment D dimer from stabilized fibrin and a study of its antipolymerization action].
    Musialkovskaia AA, Khodorova EL, Pozdniakova TM.
    Ukr Biokhim Zh; 1976 Jul 15; 48(2):139-43. PubMed ID: 941302
    [Abstract] [Full Text] [Related]

  • 19. Development of an in vitro fibrin clot model to evaluate fibrinolytic agents for wound care application.
    Viennet C, Laurensou C, Goydadin AC, Faivre B, Muret P, Humbert P.
    J Wound Care; 2014 Feb 15; 23(2):66-7, 70, 72. PubMed ID: 24526082
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
    Flood VH, Nagaswami C, Chernysh IN, Al-Mondhiry HA, Weisel JW, Farrell DH.
    Br J Haematol; 2007 Jul 15; 138(1):117-24. PubMed ID: 17555455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.